The Maple Grove-based startup says their device might be able to cure glaucoma.
Health Care + Med Tech
Blomberg earned both her Bachelor’s and Master’s degrees from the University of Minnesota.
Minneapolis Heart Institute Foundation already a national leader.
The latest investment came from Southern Minnesota Initiative Foundation philanthropists.
Minnesota Commerce Department credits rate relief to reinsurance program for high-cost claims.
The transaction is complementary to the Roseville medtech company's offerings.
The Japanese electronic components maker will pay for Vios with a mix of stock and cash.
The former chief executive of Vascular Solutions beat federal charges
of off-label use. Now he discusses his next move, and why government
oversight is hampering the medical device industry.
Most hospitals are not fully prepared to handle low-weight births.
Second early-stage trial of ‘remyelinating’ drug candidate is close to completion.
The Center for Drug Design research team is readying "Sulfanegen" for clinical trials.
St. Cloud’s city administrator called the city council’s current version of the ordinance a “hybrid” of its existing law and of what had been enacted in Edina.
Report says employees paid record 31% of annual premium for family benefits.
New collaboration is clinic’s second in emerging personalized wellness field.
CHI St. Gabriel’s Health to outline program for Congress.
The hip eyewear company previously didn't accept vision insurance.
CSI shares hit a six-month low after it warned Harvey and Irma will have a negative impact on quarterly sales guidance.
Instead of prescribing an opioid-based treatment plan, the Intellis system offers doctors a non-opioid approach to treating chronic back pain.